- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/62 - Insulins
Patent holdings for IPC class C07K 14/62
Total number of patents in this class: 1044
10-year publication summary
|
69
|
79
|
75
|
92
|
76
|
74
|
64
|
66
|
65
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novo Nordisk A/S | 2290 |
75 |
| Case Western Reserve University | 1854 |
53 |
| Hanmi Pharm. Co., Ltd. | 586 |
38 |
| Modernatx, Inc. | 1276 |
33 |
| Merck Sharp & Dohme LLC | 3745 |
30 |
| Eli Lilly and Company | 3957 |
27 |
| Sanofi-Aventis Deutschland GmbH | 2608 |
18 |
| Biocon Limited | 222 |
17 |
| Chemical & Biopharmaceutical Laboratories of Patras S.A. | 28 |
17 |
| Dechra Limited | 115 |
17 |
| Akston Biosciences Corporation | 38 |
17 |
| Merck Sharp & Dohme Corp. | 2187 |
16 |
| Sanofi | 4152 |
16 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1580 |
14 |
| Quiapeg Pharmaceuticals AB | 44 |
13 |
| Protomer Technologies, Inc. | 19 |
12 |
| Indiana University Research and Technology Corporation | 797 |
11 |
| The Trustees of Indiana University | 787 |
11 |
| GAN & Lee Pharmaceuticals Co., Ltd. | 50 |
11 |
| Codexis, Inc. | 821 |
10 |
| Other owners | 588 |